Dean G Stathakis

Title: Dean G Stathakis: Innovator in Clostridial Toxins and Neurological Treatments

Introduction

Dean G Stathakis is a notable inventor based in Irvine, CA. He has made significant contributions to the field of biotechnology, particularly in the development of methods related to clostridial toxins and treatments for urogenital-neurological disorders. With a total of 2 patents, his work has the potential to impact medical treatments significantly.

Latest Patents

Stathakis's latest patents include innovative methods of activating clostridial toxins. The specification discloses modified clostridial toxins that comprise an exogenous clostridial toxin di-chain loop protease cleavage site located within the di-chain loop region. Additionally, it covers polynucleotide molecules encoding such modified clostridial toxins, methods of producing these toxins, and methods of activating both modified and recombinantly-expressed clostridial toxins. Another significant patent focuses on methods of treating urogenital-neurological disorders using galanin retargeted endopeptidases. This specification discloses TVEMPs, compositions comprising such toxins, and methods for treating these disorders in mammals.

Career Highlights

Throughout his career, Dean G Stathakis has worked with prominent companies such as Allergan, Inc. and Irvine, Inc. His experience in these organizations has contributed to his expertise in the field of biotechnology and medical innovations.

Collaborations

Stathakis has collaborated with notable professionals in his field, including Marc F Verhagen and Lance Steward. These collaborations have likely enhanced his research and development efforts.

Conclusion

Dean G Stathakis is a distinguished inventor whose work in clostridial toxins and neurological treatments showcases his innovative spirit. His contributions to biotechnology are paving the way for advancements in medical treatments.